If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
120.20    -4.00 (-3.22%)
Bid:
120.20
Ask:
120.60
Spread: 0.40 (0.333%)
Market Cap: £292.59m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

23 Nov 2023 07:00

RNS Number : 3805U
PureTech Health PLC
23 November 2023
 

23 November 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

22 November 2023

Number of ordinary shares purchased:

49,514

Highest price paid per share:

169.00p

Lowest price paid per share:

164.40p

Volume weighted average price paid per share:

166.60p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,507,606 ordinary shares in treasury and has 272,960,553 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,960,553 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

22/11/2023

09:17:53

7

167.2

CHIX

00379426355TRLO0.1.1

22/11/2023

09:26:03

196

166.4

AQXE

00379428323TRLO0.1.1

22/11/2023

09:26:03

379

166.4

CHIX

00379428324TRLO0.1.1

22/11/2023

09:26:03

151

166.4

CHIX

00379428325TRLO0.1.1

22/11/2023

09:26:03

497

165.4

BATE

00379428328TRLO0.1.1

22/11/2023

09:26:03

1590

166.4

XLON

00379428327TRLO0.1.1

22/11/2023

09:26:03

53

165.4

TRQX

00379428331TRLO0.1.1

22/11/2023

09:26:03

65

165.4

TRQX

00379428330TRLO0.1.1

22/11/2023

09:37:16

1060

164.4

XLON

00379431286TRLO0.1.1

22/11/2023

09:37:50

487

164.4

XLON

00379431408TRLO0.1.1

22/11/2023

09:37:50

43

164.4

XLON

00379431409TRLO0.1.1

22/11/2023

09:45:04

530

164.4

XLON

00379433012TRLO0.1.1

22/11/2023

10:03:07

3

165.6

CHIX

00379437915TRLO0.1.1

22/11/2023

10:04:08

1

165.6

CHIX

00379438079TRLO0.1.1

22/11/2023

10:05:58

7

165.6

CHIX

00379438938TRLO0.1.1

22/11/2023

10:07:00

1

165.6

CHIX

00379439177TRLO0.1.1

22/11/2023

10:09:00

7

165.6

CHIX

00379439892TRLO0.1.1

22/11/2023

11:16:29

8

166.6

CHIX

00379453154TRLO0.1.1

22/11/2023

12:10:25

2650

166

XLON

00379463247TRLO0.1.1

22/11/2023

12:28:26

62

166.8

CHIX

00379466246TRLO0.1.1

22/11/2023

12:28:26

3

166.8

CHIX

00379466247TRLO0.1.1

22/11/2023

12:59:20

137

169

XLON

00379472488TRLO0.1.1

22/11/2023

13:14:56

530

169

XLON

00379475362TRLO0.1.1

22/11/2023

13:14:56

48

168.2

BATE

00379475363TRLO0.1.1

22/11/2023

13:22:12

126

169

XLON

00379477011TRLO0.1.1

22/11/2023

13:23:45

1464

168.6

XLON

00379477422TRLO0.1.1

22/11/2023

13:27:48

168

168.2

AQXE

00379478156TRLO0.1.1

22/11/2023

13:27:48

530

168.2

CHIX

00379478158TRLO0.1.1

22/11/2023

13:27:48

379

168.2

BATE

00379478157TRLO0.1.1

22/11/2023

13:27:48

530

168.2

CHIX

00379478159TRLO0.1.1

22/11/2023

13:27:48

22

167.6

TRQX

00379478160TRLO0.1.1

22/11/2023

13:27:48

79

167.6

TRQX

00379478161TRLO0.1.1

22/11/2023

13:58:45

530

168.2

CHIX

00379484857TRLO0.1.1

22/11/2023

13:58:45

1590

168.2

XLON

00379484858TRLO0.1.1

22/11/2023

14:10:17

427

167.6

BATE

00379487471TRLO0.1.1

22/11/2023

14:10:17

427

167.6

BATE

00379487472TRLO0.1.1

22/11/2023

14:10:17

47

167.4

XLON

00379487473TRLO0.1.1

22/11/2023

14:10:17

530

167.4

CHIX

00379487475TRLO0.1.1

22/11/2023

14:10:17

1013

167.4

XLON

00379487474TRLO0.1.1

22/11/2023

14:10:17

583

167.2

XLON

00379487476TRLO0.1.1

22/11/2023

14:10:21

20

167

XLON

00379487483TRLO0.1.1

22/11/2023

14:21:50

15

167.2

TRQX

00379490473TRLO0.1.1

22/11/2023

14:30:31

36

167.2

AQXE

00379494316TRLO0.1.1

22/11/2023

14:32:07

27

167.2

AQXE

00379495251TRLO0.1.1

22/11/2023

14:32:40

1188

167.2

XLON

00379495423TRLO0.1.1

22/11/2023

14:32:50

699

167.2

XLON

00379495558TRLO0.1.1

22/11/2023

14:32:50

3294

167

XLON

00379495559TRLO0.1.1

22/11/2023

14:32:50

62

167

XLON

00379495560TRLO0.1.1

22/11/2023

14:32:50

3232

167

XLON

00379495561TRLO0.1.1

22/11/2023

14:32:54

101

167

XLON

00379495649TRLO0.1.1

22/11/2023

14:33:04

273

167.2

AQXE

00379495812TRLO0.1.1

22/11/2023

14:34:09

182

166.4

AQXE

00379496556TRLO0.1.1

22/11/2023

14:34:09

91

166.4

AQXE

00379496558TRLO0.1.1

22/11/2023

14:34:09

427

166.2

BATE

00379496559TRLO0.1.1

22/11/2023

14:36:02

7

166.6

CHIX

00379498215TRLO0.1.1

22/11/2023

14:36:52

1

166.6

CHIX

00379498842TRLO0.1.1

22/11/2023

14:37:51

23

166.6

CHIX

00379499510TRLO0.1.1

22/11/2023

14:38:54

7

166.6

CHIX

00379500172TRLO0.1.1

22/11/2023

14:39:46

1

166.6

CHIX

00379501023TRLO0.1.1

22/11/2023

14:56:00

2

166.2

AQXE

00379511316TRLO0.1.1

22/11/2023

15:03:43

231

166.2

AQXE

00379518089TRLO0.1.1

22/11/2023

15:03:43

134

166.2

AQXE

00379518090TRLO0.1.1

22/11/2023

15:03:43

67

166.2

AQXE

00379518091TRLO0.1.1

22/11/2023

15:03:43

523

166.2

CHIX

00379518092TRLO0.1.1

22/11/2023

15:03:43

427

166.2

BATE

00379518093TRLO0.1.1

22/11/2023

15:03:43

345

166.2

BATE

00379518094TRLO0.1.1

22/11/2023

15:03:43

530

166.2

CHIX

00379518095TRLO0.1.1

22/11/2023

15:03:43

891

166.2

XLON

00379518096TRLO0.1.1

22/11/2023

15:03:44

518

165.8

XLON

00379518098TRLO0.1.1

22/11/2023

15:03:44

639

166.2

XLON

00379518097TRLO0.1.1

22/11/2023

15:19:30

121

166.6

XLON

00379535559TRLO0.1.1

22/11/2023

15:19:30

139

166.6

XLON

00379535560TRLO0.1.1

22/11/2023

15:20:11

2120

166.6

XLON

00379536469TRLO0.1.1

22/11/2023

15:20:20

632

166.6

CHIX

00379536635TRLO0.1.1

22/11/2023

15:21:03

2110

166.6

XLON

00379537396TRLO0.1.1

22/11/2023

15:21:03

52

166.6

XLON

00379537398TRLO0.1.1

22/11/2023

15:21:16

66

166.6

XLON

00379537789TRLO0.1.1

22/11/2023

15:24:22

595

166.6

XLON

00379541324TRLO0.1.1

22/11/2023

15:25:17

145

166.6

XLON

00379541993TRLO0.1.1

22/11/2023

15:25:17

385

166.6

XLON

00379541995TRLO0.1.1

22/11/2023

15:26:53

7

166.6

CHIX

00379543274TRLO0.1.1

22/11/2023

15:28:16

474

166.2

CHIX

00379544407TRLO0.1.1

22/11/2023

15:28:16

290

166

XLON

00379544409TRLO0.1.1

22/11/2023

15:28:16

56

166.2

CHIX

00379544408TRLO0.1.1

22/11/2023

15:28:16

2785

166

XLON

00379544410TRLO0.1.1

22/11/2023

15:28:16

140

166

XLON

00379544412TRLO0.1.1

22/11/2023

15:28:16

790

166

XLON

00379544411TRLO0.1.1

22/11/2023

15:28:16

1998

166

XLON

00379544413TRLO0.1.1

22/11/2023

15:53:33

530

166

CHIX

00379563659TRLO0.1.1

22/11/2023

15:56:17

8

166.6

AQXE

00379565850TRLO0.1.1

22/11/2023

16:00:43

130

166.6

AQXE

00379568972TRLO0.1.1

22/11/2023

16:12:32

224

165.8

XLON

00379576826TRLO0.1.1

22/11/2023

16:12:58

1

165.8

BATE

00379577110TRLO0.1.1

22/11/2023

16:13:30

2

166.6

AQXE

00379577469TRLO0.1.1

22/11/2023

16:14:14

2

166.6

AQXE

00379578066TRLO0.1.1

22/11/2023

16:14:31

2

166.6

AQXE

00379578243TRLO0.1.1

22/11/2023

16:14:59

2

166.6

AQXE

00379578505TRLO0.1.1

22/11/2023

16:16:00

2

166.6

AQXE

00379579212TRLO0.1.1

22/11/2023

16:16:12

2

166.6

AQXE

00379579308TRLO0.1.1

22/11/2023

16:16:30

2

166.6

AQXE

00379579427TRLO0.1.1

22/11/2023

16:16:50

31

166.6

TRQX

00379579573TRLO0.1.1

22/11/2023

16:22:10

530

165.8

CHIX

00379581939TRLO0.1.1

22/11/2023

16:22:10

663

165.8

XLON

00379581940TRLO0.1.1

22/11/2023

16:22:10

284

165.6

XLON

00379581943TRLO0.1.1

22/11/2023

16:22:10

784

165.8

XLON

00379581942TRLO0.1.1

22/11/2023

16:22:10

276

165.8

XLON

00379581941TRLO0.1.1

22/11/2023

16:22:10

119

165.6

XLON

00379581944TRLO0.1.1

22/11/2023

16:22:12

149

166.2

AQXE

00379581948TRLO0.1.1

22/11/2023

16:22:13

34

166.2

TRQX

00379581971TRLO0.1.1

22/11/2023

16:22:13

128

166.2

TRQX

00379581972TRLO0.1.1

22/11/2023

16:22:14

669

166.2

BATE

00379581978TRLO0.1.1

22/11/2023

16:22:32

1

166.2

BATE

00379582086TRLO0.1.1

22/11/2023

16:22:48

52

166.2

BATE

00379582181TRLO0.1.1

22/11/2023

16:23:14

168

165.2

AQXE

00379582329TRLO0.1.1

22/11/2023

16:23:20

101

166.2

TRQX

00379582367TRLO0.1.1

22/11/2023

16:23:42

10

166

BATE

00379582522TRLO0.1.1

22/11/2023

16:25:58

400

166

BATE

00379583593TRLO0.1.1

22/11/2023

16:26:48

1

166

CHIX

00379584173TRLO0.1.1

22/11/2023

16:27:30

7

166

CHIX

00379584905TRLO0.1.1

22/11/2023

16:28:07

4

166

TRQX

00379585442TRLO0.1.1

22/11/2023

16:28:34

6

166

CHIX

00379585822TRLO0.1.1

22/11/2023

16:29:39

29

166

BATE

00379586672TRLO0.1.1

22/11/2023

16:29:39

144

166

BATE

00379586673TRLO0.1.1

22/11/2023

16:29:39

57

166

BATE

00379586675TRLO0.1.1

22/11/2023

16:29:40

87

166

CHIX

00379586686TRLO0.1.1

22/11/2023

16:29:40

7

166

CHIX

00379586687TRLO0.1.1

22/11/2023

16:29:51

7

166

CHIX

00379586889TRLO0.1.1

22/11/2023

16:29:51

1

166

CHIX

00379586895TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFDLALFFIV
Date   Source Headline
2nd Jul 20267:01 amRNSPRTC Launches Celea w/ $180M & Top Tier Syndicate
2nd Jul 20267:00 amRNSPRTC Launches Celea: $180M & Asset Transfer
10th Jun 20265:38 pmRNSResult of AGM
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.